Issues raised by the incidence and survival of childhood cancers

Messages for ultraviolet-radiation protection to fair-skinned populations.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025

Evaluation of screening mammography effectiveness: The IARC recommendations of 2015 need revision.

European journal of cancer (Oxford, England : 1990)·2025

Self-Selection Bias in Randomized and Observational Studies on Screening Mammography: A Quantitative Assessment.

Clinical epidemiology·2025

Vitamin D, acute respiratory infections, and Covid-19: The curse of small-size randomised trials. A critical review with meta-analysis of randomised trials.

PloS one·2025

Skin cancer in Europe today and challenges for tomorrow.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Long-Term Safety of Teriflunomide in Multiple Sclerosis Patients: Results of Prospective Comparative Studies in Three European Countries.

Pharmacoepidemiology and drug safety·2024

At the heart of unmet need: TP53 myeloid neoplasms.

The Lancet. Haematology·2026

Felzartamab plus lenalidomide-dexamethasone versus lenalidomide-dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial.

The Lancet. Haematology·2026

Rilzabrutinib, an oral Bruton tyrosine kinase inhibitor, in patients with warm autoimmune haemolytic anaemia: a prospective, single-arm, multicentre, phase 2b safety and clinical activity study (LUMINA 2).

The Lancet. Haematology·2026

Clinical activity and safety of rilzabrutinib in patients with previously treated immune thrombocytopenia (LUNA3): results from the open-label period of a phase 3 trial.

The Lancet. Haematology·2026

Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial.

The Lancet. Haematology·2026

High time for risk-adapted treatment in mantle cell lymphoma.

The Lancet. Haematology·2026

Large-conductance calcium-activated potassium (BK) channels regulate respiratory, metabolic and behavioural responses to CO2/pH in mice.

The Journal of physiology·2026

Metabolic dysfunction and GZMK+ CD8+ T-cell remodeling in hepatocellular carcinoma: an evidence-stratified, hypothesis-generating review.

Frontiers in immunology·2026

Distinct responses of COL17A1 nonsense variants to readthrough drugs and NOG as a novel enhancer in junctional epidermolysis bullosa.

Molecular therapy. Nucleic acids·2026

Incidence of Gynecological Cancers Is Rising in Northern Iran: A Population-Based, Serial Cross-Sectional Joinpoint Regression Study.

Health science reports·2026

Mechanistic insights into VSIR-mediated AXL regulation and gastric cancer proliferation.

iScience·2026

Meso-scale spatial analysis of papilloma formation and clonal expansion in cancerized skin.

Genome research·2026

Related Experiment Videos

Issues raised by the incidence and survival of childhood cancers

Related Concept Videos

Messages for ultraviolet-radiation protection to fair-skinned populations.

Evaluation of screening mammography effectiveness: The IARC recommendations of 2015 need revision.

Self-Selection Bias in Randomized and Observational Studies on Screening Mammography: A Quantitative Assessment.

Vitamin D, acute respiratory infections, and Covid-19: The curse of small-size randomised trials. A critical review with meta-analysis of randomised trials.

Skin cancer in Europe today and challenges for tomorrow.

Long-Term Safety of Teriflunomide in Multiple Sclerosis Patients: Results of Prospective Comparative Studies in Three European Countries.

At the heart of unmet need: TP53 myeloid neoplasms.

Felzartamab plus lenalidomide-dexamethasone versus lenalidomide-dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial.

Rilzabrutinib, an oral Bruton tyrosine kinase inhibitor, in patients with warm autoimmune haemolytic anaemia: a prospective, single-arm, multicentre, phase 2b safety and clinical activity study (LUMINA 2).

Clinical activity and safety of rilzabrutinib in patients with previously treated immune thrombocytopenia (LUNA3): results from the open-label period of a phase 3 trial.

Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial.

High time for risk-adapted treatment in mantle cell lymphoma.

Large-conductance calcium-activated potassium (BK) channels regulate respiratory, metabolic and behavioural responses to CO2/pH in mice.

Metabolic dysfunction and GZMK+ CD8+ T-cell remodeling in hepatocellular carcinoma: an evidence-stratified, hypothesis-generating review.

Distinct responses of COL17A1 nonsense variants to readthrough drugs and NOG as a novel enhancer in junctional epidermolysis bullosa.

Incidence of Gynecological Cancers Is Rising in Northern Iran: A Population-Based, Serial Cross-Sectional Joinpoint Regression Study.

Mechanistic insights into VSIR-mediated AXL regulation and gastric cancer proliferation.

Meso-scale spatial analysis of papilloma formation and clonal expansion in cancerized skin.

Related Experiment Videos

Issues raised by the incidence and survival of childhood cancers

Related Concept Videos

Related Articles